Showing posts with label Dermatology. Show all posts
Showing posts with label Dermatology. Show all posts

Wednesday, 17 May 2017

Global Telemedicine Market and Services Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

Researchmoz added Most up-to-date research on "Global Telemedicine Market (Specialty, Cardiology, Dermatology, Neurology, Orthopedics, Emergency Care, Internal Medicine, Gynecology, and Others) and Services (Tele-Consultation, Tele-Monitoring, Tele-Education, Tele-Training, Tele-Care, and Tele-Surgery) - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" to its huge collection of research reports.

Telemedicine is the evolved format of traditional medicine that provides medical care to millions of individuals worldwide with the benefits of cost efficiency and convenience of location. The basic difference between traditional healthcare technology and telemedicine is the use of telecommunication technology to provide patients and medical practitioners the convenience of location, cost and time. With the advent of communication technology in medical sciences, telemedicine revolutionized the overall framework of healthcare. Patients were no longer subjected to travel or waiting periods and could seek medical attention at the comfort of their homes. This greatly changed the perception of medical practice, which is the major reason why telemedicine is currently considered synonymous with general medicine. Telemedicine involves the use of mobile communication technology and image/video transfer technology via the internet. The internet has provided the basis for information exchange, which is
stored and maintained by the servers present at either hospitals or telemedicine service provider company at a nominal cost. 

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=222492

This research report provides a detailed analysis of the global telemedicine market and helps in understanding the various factors influencing the growth of the market. The market overview section analyzes market dynamics and trends such as drivers, restraints and opportunities that influence the current nature and future status of the global telemedicine market. The executive summary provides detailed insights about this study and the market in general. It also contains a market snapshot, which provides a glimpse into the present scenario of the global telemedicine market. Impact factors such as market attractiveness analysis and Porter’s five forces analysis have also been explained in the market overview section of the report in order to deliver a thorough analysis of the overall competitive scenario of the global telemedicine market.

The global telemedicine market is segmented based on medical specialty areas and type of services being offered/used. Based on the type of specialties, the market is segmented into cardiology, neurology, dermatology, orthopedics, emergency care, internal medicine, gynecology and other specialty areas namely gastroenterology, pediatric care, ophthalmology and dentistry. Based on type of services being offered/ used, the market is categorized into tele-consultation, tele-monitoring, tele-education, tele-training, tele-care, and tele-surgery. Market size estimates and forecasts for the period 2012 to 2020 have been provided for each of the segments mentioned above in terms of USD million, considering 2013 as the base year for calculating market forecast and 2012 as the historical year. The CAGR (%) of each market segment for the forecast period 2014 to 2020 has also been provided along with market size estimations.

Geographically, the global telemedicine market has been segmented into four major regions: North America, Europe, Asia Pacific and Rest of World (RoW), with Russia being included in the RoW region. The market size estimations and forecasts for the period 2012 to 2020 have been provided for each of these regions at a segment level, in terms of USD million along with the CAGR for the forecast period 2014 to 2020. This study further offers strategic recommendations for the global telemedicine market. These include factors that may play a critical role in enhancing or boosting the market in the near future, as well as steps that need to be considered to ensure success for manufacturers.

The report concludes with the company profiles section and includes key information about the major players who are actively participating in this market. The company profiles included in the report is framed in terms of company overview, financial overview, business strategies, recent developments and product portfolio. Key players profiled in this report include Agfa HealthCare NV, Allscripts Healthcare Solutions, Inc., AMD Global Telemedicine, Inc., CARDIOCOM, LLC, CISCO Systems, Inc., F. Hoffmann-La Roche Ltd., Honeywell HomMed LLC, InTouch Technologies, Inc., LifeWatch AG, Medtronic, Inc., OBS Medical Ltd., Siemens Healthcare, and McKesson Corp.

The global telemedicine market is segmented as follows:

Telemedicine Market, by Specialty

- Cardiology
- Dermatology
- Neurology
- Orthopedics
- Emergency Care
- Internal Medicine
- Gynecology
- Others

Telemedicine Market, by Service Type

- Tele-consultation
- Tele-monitoring
- Tele-education
- Tele-care
- Tele-training
- Tele-surgery
- Telemedicine Market, by Geography
- North America
- Europe
- Asia Pacific
- Rest of the World (RoW)

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=222492

Tuesday, 16 May 2017

Global Dermatology Drug Market Analysis, Trend, Growth, Size, Share and Professional Survey Report 2017

Researchmoz added Most up-to-date research on "Global Dermatology Drug Market Professional Survey Report 2017" to its huge collection of research reports.

This report studies Dermatology Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Rishiroop Group
Bech Chem
Ruize Chemical
Shandong Tianchen Chemical
Fujian Wantaixing Chemical Development
Fenghua YURON Chemical Industry Material

By types, the market can be split into
lotion
Ointment

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=911139

By Application, the market can be split into
Hospital
Clinic
Other

By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India

Table of Contents

Global Dermatology Drug Market Professional Survey Report 2017
1 Industry Overview of Dermatology Drug
1.1 Definition and Specifications of Dermatology Drug
1.1.1 Definition of Dermatology Drug
1.1.2 Specifications of Dermatology Drug
1.2 Classification of Dermatology Drug
1.2.1 lotion
1.2.2 Ointment
1.3 Applications of Dermatology Drug
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Other
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India

2 Manufacturing Cost Structure Analysis of Dermatology Drug
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Dermatology Drug
2.3 Manufacturing Process Analysis of Dermatology Drug
2.4 Industry Chain Structure of Dermatology Drug

3 Technical Data and Manufacturing Plants Analysis of Dermatology Drug
3.1 Capacity and Commercial Production Date of Global Dermatology Drug Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Dermatology Drug Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Dermatology Drug Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Dermatology Drug Major Manufacturers in 2015

4 Global Dermatology Drug Overall Market Overview
4.1 2011-2016 Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2011-2016 Global Dermatology Drug Capacity and Growth Rate Analysis
4.2.2 2015 Dermatology Drug Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2016 Global Dermatology Drug Sales and Growth Rate Analysis
4.3.2 2015 Dermatology Drug Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2016 Global Dermatology Drug Sales Price
4.4.2 2015 Dermatology Drug Sales Price Analysis (Company Segment)

5 Dermatology Drug Regional Market Analysis
5.1 North America Dermatology Drug Market Analysis
5.1.1 North America Dermatology Drug Market Overview
5.1.2 North America 2011-2016 Dermatology Drug Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2011-2016 Dermatology Drug Sales Price Analysis
5.1.4 North America 2015 Dermatology Drug Market Share Analysis
5.2 China Dermatology Drug Market Analysis
5.2.1 China Dermatology Drug Market Overview
5.2.2 China 2011-2016 Dermatology Drug Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2011-2016 Dermatology Drug Sales Price Analysis
5.2.4 China 2015 Dermatology Drug Market Share Analysis
5.3 Europe Dermatology Drug Market Analysis
5.3.1 Europe Dermatology Drug Market Overview
5.3.2 Europe 2011-2016 Dermatology Drug Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2011-2016 Dermatology Drug Sales Price Analysis
5.3.4 Europe 2015 Dermatology Drug Market Share Analysis
5.4 Southeast Asia Dermatology Drug Market Analysis
5.4.1 Southeast Asia Dermatology Drug Market Overview
5.4.2 Southeast Asia 2011-2016 Dermatology Drug Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2011-2016 Dermatology Drug Sales Price Analysis
5.4.4 Southeast Asia 2015 Dermatology Drug Market Share Analysis
5.5 Japan Dermatology Drug Market Analysis
5.5.1 Japan Dermatology Drug Market Overview
5.5.2 Japan 2011-2016 Dermatology Drug Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2011-2016 Dermatology Drug Sales Price Analysis
5.5.4 Japan 2015 Dermatology Drug Market Share Analysis
5.6 India Dermatology Drug Market Analysis
5.6.1 India Dermatology Drug Market Overview
5.6.2 India 2011-2016 Dermatology Drug Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2011-2016 Dermatology Drug Sales Price Analysis
5.6.4 India 2015 Dermatology Drug Market Share Analysis

6 Global 2011-2016 Dermatology Drug Segment Market Analysis (by Type)
6.1 Global 2011-2016 Dermatology Drug Sales by Type
6.2 Different Types of Dermatology Drug Product Interview Price Analysis
6.3 Different Types of Dermatology Drug Product Driving Factors Analysis
6.3.1 lotion of Dermatology Drug Growth Driving Factor Analysis
6.3.2 Ointment of Dermatology Drug Growth Driving Factor Analysis

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=911139

Monday, 17 April 2017

Global Dermatology Market Is Projected To Grow At A Considerable Compound Annual Growth Rate (CAGR) Of 7.73%, Reaching $33.7 Billion In 2022

Researchmoz added Most up-to-date research on "Global Dermatology Market to 2022 - Innovative Pipeline and Increasing Uptake of Biologics to Diversify Treatment Options and Drive Strong Growth" to its huge collection of research reports.

Dermatological conditions are one of the most common types of disorders worldwide, and approximately one-third of the US population suffers from at least one active skin condition.For the past decades, the majority of the dermatology market has remained saturated with established products. However, the clinical and commercial success of biologics in the treatment of psoriasis, as well as advancements in the understanding of the disease pathways of many dermatological conditions, have led to a renewed interest from pharmaceutical companies in the dermatology market, and subsequently the emergence of an innovative pipeline.

This report covers all dermatological disorders, but there is a particular focus on three key diseases: atopic dermatitis, acne vulgaris and psoriasis, as these conditions have the highest prevalence and the largest pipeline. The global dermatology market was valued at $20.0 billion in 2015, and is projected to grow at a considerable Compound Annual Growth Rate (CAGR) of 7.73%, reaching $33.7 billion in 2022. Key drivers of this growth will be the uptake of recently approved premium biologics, as well as promising late-stage products that are expected to be highly valuable.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=725316

Scope

The dermatology market landscape is expected to change substantially with the advent of promising novel pipeline products.

Overall, there are 801 dermatology products in the pipeline, with biologics representing 37% of the pipeline, despite the fact that this molecule type represents only a small fraction of the marketed products landscape.

- Which molecular targets are most prominent within the pipeline?
- How do the key indications differ in terms of molecule type?
- How does the composition of the pipeline compare with that of the existing market?
- What mechanisms of action are most common for pipeline drugs?

Global revenues for the dermatology market are forecast to grow at a CAGR of 7.73%, from $20 billion in 2015 to $33.7 billion in 2022.

- Which products will contribute to market growth most significantly, and which will achieve blockbuster status?
- Will the current market leaders retain their dominance over the forecast period, and how is their revenue share of the dermatology market set to change?
- What CAGR will these companies register in the forecast period?

Reasons to buy

This report will allow you to -

- Understand the current clinical and commercial landscape by considering disease pathogenesis, diagnosis, prognosis and the treatment options available at each stage of diagnosis.
- Visualize the composition of the dermatology market across each indication, in terms of dominant molecule types and targets, highlighting the key commercial assets and players.
- Analyze the dermatology pipeline and stratify by stage of development, molecule type and molecular target, with a granular breakdown across key indications.
- Understand the growth in patient epidemiology and market revenues for the dermatology market globally, and across the key players and product types.
- Stratify the market in terms of the split between generic and premium products, and assess the role of these product types in the treatment of the various dermatological conditions.
- Identify commercial opportunities in the dermatology deals landscape by analyzing trends in licensing and co-development deals.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=725316

Monday, 27 February 2017

Global Dermatology Market Is Projected To Grow At A Considerable Compound Annual Growth Rate (CAGR) Of 7.73%, Reaching $33.7 Billion In 2022

Researchmoz added Most up-to-date research on "Global Dermatology Market to 2022 - Innovative Pipeline and Increasing Uptake of Biologics to Diversify Treatment Options and Drive Strong Growth" to its huge collection of research reports.

Dermatological conditions are one of the most common types of disorders worldwide, and approximately one-third of the US population suffers from at least one active skin condition.For the past decades, the majority of the dermatology market has remained saturated with established products. However, the clinical and commercial success of biologics in the treatment of psoriasis, as well as advancements in the understanding of the disease pathways of many dermatological conditions, have led to a renewed interest from pharmaceutical companies in the dermatology market, and subsequently the emergence of an innovative pipeline.

This report covers all dermatological disorders, but there is a particular focus on three key diseases: atopic dermatitis, acne vulgaris and psoriasis, as these conditions have the highest prevalence and the largest pipeline. The global dermatology market was valued at $20.0 billion in 2015, and is projected to grow at a considerable Compound Annual Growth Rate (CAGR) of 7.73%, reaching $33.7 billion in 2022. Key drivers of this growth will be the uptake of recently approved premium biologics, as well as promising late-stage products that are expected to be highly valuable.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=725316

Scope

The dermatology market landscape is expected to change substantially with the advent of promising novel pipeline products.

Overall, there are 801 dermatology products in the pipeline, with biologics representing 37% of the pipeline, despite the fact that this molecule type represents only a small fraction of the marketed products landscape.

- Which molecular targets are most prominent within the pipeline?
- How do the key indications differ in terms of molecule type?
- How does the composition of the pipeline compare with that of the existing market?
- What mechanisms of action are most common for pipeline drugs?

Global revenues for the dermatology market are forecast to grow at a CAGR of 7.73%, from $20 billion in 2015 to $33.7 billion in 2022.

- Which products will contribute to market growth most significantly, and which will achieve blockbuster status?
- Will the current market leaders retain their dominance over the forecast period, and how is their revenue share of the dermatology market set to change?
- What CAGR will these companies register in the forecast period?

Reasons to buy

This report will allow you to -

- Understand the current clinical and commercial landscape by considering disease pathogenesis, diagnosis, prognosis and the treatment options available at each stage of diagnosis.
- Visualize the composition of the dermatology market across each indication, in terms of dominant molecule types and targets, highlighting the key commercial assets and players.
- Analyze the dermatology pipeline and stratify by stage of development, molecule type and molecular target, with a granular breakdown across key indications.
- Understand the growth in patient epidemiology and market revenues for the dermatology market globally, and across the key players and product types.
- Stratify the market in terms of the split between generic and premium products, and assess the role of these product types in the treatment of the various dermatological conditions.
- Identify commercial opportunities in the dermatology deals landscape by analyzing trends in licensing and co-development deals.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=725316

Friday, 10 February 2017

Global revenues for the dermatology market are forecast to grow at a CAGR of 7.73%, from $20 billion in 2015 to $33.7 billion in 2022

Researchmoz added Most up-to-date research on "Global Dermatology Market to 2022 - Innovative Pipeline and Increasing Uptake of Biologics to Diversify Treatment Options and Drive Strong Growth" to its huge collection of research reports.

Dermatological conditions are one of the most common types of disorders worldwide, and approximately one-third of the US population suffers from at least one active skin condition.For the past decades, the majority of the dermatology market has remained saturated with established products. However, the clinical and commercial success of biologics in the treatment of psoriasis, as well as advancements in the understanding of the disease pathways of many dermatological conditions, have led to a renewed interest from pharmaceutical companies in the dermatology market, and subsequently the emergence of an innovative pipeline.

This report covers all dermatological disorders, but there is a particular focus on three key diseases: atopic dermatitis, acne vulgaris and psoriasis, as these conditions have the highest prevalence and the largest pipeline. The global dermatology market was valued at $20.0 billion in 2015, and is projected to grow at a considerable Compound Annual Growth Rate (CAGR) of 7.73%, reaching $33.7 billion in 2022. Key drivers of this growth will be the uptake of recently approved premium biologics, as well as promising late-stage products that are expected to be highly valuable.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=725316

Scope

The dermatology market landscape is expected to change substantially with the advent of promising novel pipeline products.

Overall, there are 801 dermatology products in the pipeline, with biologics representing 37% of the pipeline, despite the fact that this molecule type represents only a small fraction of the marketed products landscape.

- Which molecular targets are most prominent within the pipeline?
- How do the key indications differ in terms of molecule type?
- How does the composition of the pipeline compare with that of the existing market?
- What mechanisms of action are most common for pipeline drugs?

Global revenues for the dermatology market are forecast to grow at a CAGR of 7.73%, from $20 billion in 2015 to $33.7 billion in 2022.

- Which products will contribute to market growth most significantly, and which will achieve blockbuster status?
- Will the current market leaders retain their dominance over the forecast period, and how is their revenue share of the dermatology market set to change?
- What CAGR will these companies register in the forecast period?

Reasons to buy

This report will allow you to -

- Understand the current clinical and commercial landscape by considering disease pathogenesis, diagnosis, prognosis and the treatment options available at each stage of diagnosis.
- Visualize the composition of the dermatology market across each indication, in terms of dominant molecule types and targets, highlighting the key commercial assets and players.
- Analyze the dermatology pipeline and stratify by stage of development, molecule type and molecular target, with a granular breakdown across key indications.
- Understand the growth in patient epidemiology and market revenues for the dermatology market globally, and across the key players and product types.
- Stratify the market in terms of the split between generic and premium products, and assess the role of these product types in the treatment of the various dermatological conditions.
- Identify commercial opportunities in the dermatology deals landscape by analyzing trends in licensing and co-development deals.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=725316

Blood Thawing System Market Insights Shared in Detailed Report

Blood Thawing System Market: Introduction According to the report, the global  blood thawing system market  was valued at ~US$ 174 Mn in 2...